Streamlining Clinical Trials: FDA Guidance Meets RBQM Strategy
The recently launched FDA’s draft guidance on protocol deviations highlights the importance of compliance and risk management. Combined with RBQM principles, sponsors can streamline trials, enhance safety, and align with regulations.
